Related Experiment Video
Updated: Jul 25, 2025
07:51
The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
Published on: June 1, 2019
19.7K
Sentinel Lymph Node Detection in Breast Cancer: An Innovative Technique
Paolo Izzo1, Claudia De Intinis1, Simone Sibio1
1Department of Surgery "Pietro Valdoni", Policlinico "Umberto I", Rome "Sapienza" University of Rome, 00128 Rome, Italy.
Diagnostics (Basel, Switzerland)
|June 28, 2023
Summary
Sentinel lymph node biopsy using magnetic tracer technology (Sentimag) shows high identification rates comparable to radioactive tracers. This method avoids radiation exposure, reducing costs and time for breast cancer patients.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Sentinel lymph node biopsy (SLNB) is crucial for staging breast cancer metastasis.
- Complications of traditional SLNB include seroma, pain, hypoesthesia, and motor deficits.
Purpose of the Study:
- To evaluate novel techniques for SLNB to minimize postoperative complications.
- To present initial data on the efficacy of magnetic tracer technology for SLNB.
Main Methods:
- Two detection techniques were employed: radioactive tracers and magnetic tracer technology (Sentimag-magtrace).
- Histologic analysis was performed on identified positive lymph nodes.
- The study included 100 patients undergoing breast cancer surgery.
Main Results:
- The identification rate for radioactive tracers was 88.9%.
- The identification rate for magnetic tracer technology (Sentimag) was 89.5%.
- Both methods demonstrated comparable efficacy in sentinel lymph node detection.
Conclusions:
- Magnetic tracer technology offers a viable alternative to radioactive tracers for SLNB.
- This technique eliminates radiation exposure for patients and healthcare providers.
- The Sentimag-magtrace method potentially reduces healthcare costs and procedure time.
